{"nctId":"NCT02352363","briefTitle":"Randomized Safety Study of CVT-301 Compared to an Observational Control Group","startDateStruct":{"date":"2015-03"},"conditions":["Idiopathic Parkinson's Disease"],"count":408,"armGroups":[{"label":"CVT-301","type":"EXPERIMENTAL","interventionNames":["Drug: CVT-301"]},{"label":"Observational Cohort","type":"OTHER","interventionNames":["Other: Observational cohort"]}],"interventions":[{"name":"CVT-301","otherNames":["Inhaled levodopa"]},{"name":"Observational cohort","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Has signed and dated an Internal Review Board/Independent Ethics Committee (IRB/IEC)-approved informed consent form before any protocol-specific screening procedures are performed.\n* Women of child-bearing potential must use protocol-defined contraceptive measures and must have a negative serum human chorionic gonadotropin (hCG) test at screening. These patients must be willing to remain on their current form of contraception for the duration of the study.\n* Patients who have idiopathic PD (i.e., not induced by drugs or other diseases) as defined by fulfilling Steps 1 and 2 of the United Kingdom (UK) Brain Bank criteria, diagnosed after the age of 30 years.\n* Patients who are classified as Stage 1 to 3 (in the ON state) on the modified Hoehn and Yahr scale for staging of PD severity.\n* Patients who have experienced motor fluctuations for a minimum of 2 hours of average daily OFF time per waking day (excluding early morning OFF time) by self-report and confirmed by the PD Diary (on 3 consecutive days) during the screening period.\n\nExclusion Criteria:\n\n* Patients who have dyskinesia of a severity that would significantly interfere with their ability to participate or perform study procedures.\n* Pregnant or lactating females or females wishing to become pregnant.\n* Patients who have any known contraindication to the use of levodopa (LD), including a history of malignant melanoma or a history of narrow-angle glaucoma.\n* Patients who have had previous surgery for PD (including but not limited to deep brain stimulation \\[DBS\\] or cell transplantation).\n* Patients with a history of psychotic symptoms requiring treatment, or suicide ideation or attempt within the prior 12 months.","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pulmonary Safety Assessed by Forced Expiratory Volume in 1 Second [FEV1]","description":"To characterize the pulmonary safety, as assessed by spirometry (forced expiratory volume in 1 second \\[FEV1\\], over a 12 month period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.778","spread":"0.7309"},{"groupId":"OG001","value":"2.767","spread":"0.8419"}]}]}]},{"type":"PRIMARY","title":"Pulmonary Safety Assessed by Forced Vital Capacity [FVC].","description":"To characterize the pulmonary safety, as assessed by spirometry (forced vital capacity).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.558","spread":"0.8987"},{"groupId":"OG001","value":"3.642","spread":"1.0687"}]}]}]},{"type":"PRIMARY","title":"Pulmonary Safety Assessed by Forced Expiratory Volume in 1 Second / Forced Vital Capacity Ratio.","description":"To characterize the pulmonary safety, as assessed by spirometry (forced expiratory volume in 1 second / forced vital capacity ratio).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78.1","spread":"6.04"},{"groupId":"OG001","value":"76.1","spread":"6.4"}]}]}]},{"type":"SECONDARY","title":"Diffusion Capacity of the Lungs for Carbon Monoxide (DLco).","description":"To describe the effects of CVT-301 on diffusion capacity of the lungs for carbon monoxide (DLco) over a 12-month period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.273","spread":"6.0025"},{"groupId":"OG001","value":"23.473","spread":"7.0848"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":42,"n":271},"commonTop":["Cough","Fall","Nasopharyngitis","Dyskinesia","Upper respiratory tract infection"]}}}